{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T17:52:32Z","timestamp":1761155552062},"reference-count":49,"publisher":"International Heart Journal (Japanese Heart Journal)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. Heart J."],"published-print":{"date-parts":[[2011]]},"DOI":"10.1536\/ihj.52.359","type":"journal-article","created":{"date-parts":[[2011,12,22]],"date-time":"2011-12-22T06:20:13Z","timestamp":1324534813000},"page":"359-365","source":"Crossref","is-referenced-by-count":15,"title":["Long-term Efficacy of Upstream Therapy With Lipophilic or Hydrophilic Statins on Antiarrhythmic Drugs in Patients With Paroxysmal Atrial Fibrillation  Comparison Between Atorvastatin and Pravastatin"],"prefix":"10.1536","volume":"52","author":[{"given":"Takashi","family":"Komatsu","sequence":"first","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine and Memorial Heart Center, Iwate Medical University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideaki","family":"Tachibana","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine and Memorial Heart Center, Iwate Medical University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Sato","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine and Memorial Heart Center, Iwate Medical University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahito","family":"Ozawa","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine and Memorial Heart Center, Iwate Medical University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fusanori","family":"Kunugita","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine and Memorial Heart Center, Iwate Medical University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motoyuki","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine and Memorial Heart Center, Iwate Medical University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"437","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Benjamin EJ, Wolf PA, D&rsquo;Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation 1998; 98: 946-52.","DOI":"10.1161\/01.CIR.98.10.946"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham study. Arch Intern Med 1987; 147: 1561-4.","DOI":"10.1001\/archinte.1987.00370090041008"},{"key":"3","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(98)00297-6"},{"key":"4","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.105.595140"},{"key":"5","doi-asserted-by":"publisher","DOI":"10.2188\/jea.15.194"},{"key":"6","unstructured":"6. Ogawa S, Aizawa Y, Okumura K, <i>et al<\/i>. The Japanese guidelines for pharmacotherapy of atrial fibrillation (JCS 2008). Circ J 2008; 72 (Supp IV): 1581-638. (Japanese)"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Aizawa Y, Kohsaka S, Suzuki S, <i>et al<\/i>. Comparison of antiarrhythmics used in patients with paroxysmal atrial fibrillation: subanalysis of J-RHYTHM Study. Circ J 2010; 74: 71-6.","DOI":"10.1253\/circj.CJ-09-0367"},{"key":"8","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehp357"},{"key":"9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2007.09.063"},{"key":"10","doi-asserted-by":"publisher","DOI":"10.1536\/ihj.50.465"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Wagner AH, K&ouml;hler T, R&uuml;ckschloss U, Just I, Hecker M. Improvement of nitric oxide-dependent vasodilatation by HMG-CoA reductase inhibitors through attenuation of endothelial superoxide anion formation. Arterioscler Thromb Vasc Biol 2000; 20: 61-9.","DOI":"10.1161\/01.ATV.20.1.61"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Mason RP. Molecular basis of differences among statins and a comparison with antioxidant vitamins. Am J Cardiol 2006; 98: 34P-41P. (Review)","DOI":"10.1016\/j.amjcard.2006.09.018"},{"key":"13","doi-asserted-by":"publisher","DOI":"10.1002\/clc.4960270405"},{"key":"14","doi-asserted-by":"publisher","DOI":"10.1097\/FJC.0b013e318123767f"},{"key":"15","unstructured":"15. Kodama I, Aizawa Y, Okumura K, <i>et al<\/i>. The Japanese guidelines for pharmacotherapy of atrial fibrillation (JCS 2004). Circ J 2004; 68(SuppIV): 981-1053. (Japanese)"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Sopher SM, Camm AJ. Atrial fibrillation: maintenance of sinus rhythm versus rate control. Am J Cardiol 1996; 77: 24A-37A. (Review)","DOI":"10.1016\/S0002-9149(97)89115-1"},{"key":"17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2004.06.032"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Ogihara T, Kikuchi K, Matsuoka H, <i>et al<\/i>. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH2009). Hypertens Res 2009; 32: 3-107.","DOI":"10.1038\/hr.2009.34"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Investigating Committee of Guideline for Diagnosis and Treatment of Hyperlipidemias: guidelines for diagnosis and treatment of hyperlipidemia in adults. J Jpn Atheroscler Soc 1997; 25: 1-34.","DOI":"10.5551\/jat1973.25.1-2_1"},{"key":"20","doi-asserted-by":"publisher","DOI":"10.1253\/circj.68.729"},{"key":"21","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.106.177292"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Frustaci A, Chimenti C, Bellocci F, Morgante E, Russo MA, Maseri A. Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation 1997; 96: 1180-4.","DOI":"10.1161\/01.CIR.96.4.1180"},{"key":"23","doi-asserted-by":"publisher","DOI":"10.1161\/hc4901.101760"},{"key":"24","doi-asserted-by":"publisher","DOI":"10.2143\/AC.56.6.2005701"},{"key":"25","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(86)80429-6"},{"key":"26","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardiores.2004.01.018"},{"key":"27","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000103131.70301.4F"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Bruins P, te Velthuis H, Yazdanbakhsh AP, <i>et al<\/i>. Activation of the complement system during and after cardiopulmonary bypass surgery: postsurgery activation involves C-reactive protein and is associated with postoperative arrhythmia. Circulation 1997; 96: 3542-8.","DOI":"10.1161\/01.CIR.96.10.3542"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Weitz-Schmidt G. Statins as anti-inflammatory agents. Trends Pharmacol Sci 2002; 23: 482-6. (Review)","DOI":"10.1016\/S0165-6147(02)02077-1"},{"key":"30","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000080895.05158.8B"},{"key":"31","doi-asserted-by":"publisher","DOI":"10.1001\/jama.291.9.1132"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Laufs U, La Fata V, Plutzky J, Liao JK. Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors. Circulation 1998; 97: 1129-35.","DOI":"10.1161\/01.CIR.97.12.1129"},{"key":"33","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2006.05.010"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Adabag AS, Nelson DB, Bloomfield HE. Effects of statin therapy on preventing atrial fibrillation in coronary disease and heart failure. Am Heart J 2007; 154: 1140-5.","DOI":"10.1016\/j.ahj.2007.07.018"},{"key":"35","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehn198"},{"key":"36","doi-asserted-by":"publisher","DOI":"10.1185\/030079907X188026"},{"key":"37","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2007.07.137"},{"key":"38","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2007.10.024"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Dernellis J, Panaretou M. Effect of C-reactive protein reduction on paroxysmal atrial fibrillation. Am Heart J 2005; 150: 1064.","DOI":"10.1016\/j.ahj.2005.06.032"},{"key":"40","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2005.11.082"},{"key":"41","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2003.08.023"},{"key":"42","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2003.12.009"},{"key":"43","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.106.621763"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Komatsu T, Tachibana H, Sato Y, <i>et al<\/i>. Long-term efficacy of combination therapy with anti-arrhythmic agents and pravastatin in patients with paroxysmal atrial fibrillation. J Arrhythmia 2007; 23: 124-30.","DOI":"10.1016\/S1880-4276(07)80023-8"},{"key":"45","doi-asserted-by":"publisher","DOI":"10.1536\/ihj.50.153"},{"key":"46","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2008.01.028"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47. Page RL, Wilkinson WE, Clair WK, McCarthy EA, Pritchett EL. Asymptomatic arrhythmias in patients with symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia. Circulation 1994; 89: 224-7.","DOI":"10.1161\/01.CIR.89.1.224"},{"key":"48","unstructured":"48. Fukuda Y, Akashi M, Noma S, <i>et al<\/i>. Asymptomatic recurrence of atrial fibrillation - Cardiophone-guided management. Circ J 2003; 67(Suppl I): 310."},{"key":"49","doi-asserted-by":"publisher","DOI":"10.1536\/ihj.51.98"}],"container-title":["International Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/ihj\/52\/6\/52_6_359\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,19]],"date-time":"2021-04-19T07:00:34Z","timestamp":1618815634000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/ihj\/52\/6\/52_6_359\/_article"}},"subtitle":["Comparison Between Atorvastatin and Pravastatin"],"short-title":[],"issued":{"date-parts":[[2011]]},"references-count":49,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1536\/ihj.52.359","relation":{},"ISSN":["1349-2365","1349-3299"],"issn-type":[{"value":"1349-2365","type":"print"},{"value":"1349-3299","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011]]}}}